Document is current
Any future updates will be listed below
-
Authors
Faure-Dupuy, Suzanne https://orcid.org/0000-0001-7898-6795
Jubrail, Jamil https://orcid.org/0000-0002-5387-1999
Depierre, Manon
Africano-Gomez, Kshanti
Öberg, Lisa https://orcid.org/0000-0001-7127-1711
Israelsson, Elisabeth
Thörn, Kristofer
Delevoye, Cédric https://orcid.org/0000-0002-3835-6649
Castellano, Flavia https://orcid.org/0000-0001-9389-6704
Herit, Floriane https://orcid.org/0009-0006-0680-6461
Guilbert, Thomas
Russell, David G
Mayer, Gaell
Cunoosamy, Danen M https://orcid.org/0000-0002-9044-7281
Kurian, Nisha https://orcid.org/0000-0002-8384-9928
Niedergang, Florence https://orcid.org/0000-0002-7064-830X
-
Funding
Funding for this research was provided by:
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
Université Paris Cité
AstraZeneca
Fondation pour la Recherche Médicale (ARF202110013926)
EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MacroRhino)
Agence Nationale de la Recherche (ANR-10-INSB-04)
Agence Nationale de la Recherche (ANR-10-INBS-04)
Labex CelTisPhyBio (ANR-11-LABX-0038)
IDEX PSL (ANR-10-IDEX-0001-02 PSL)
- License Information
-
More Information
Article History
Received: 1 May 2023
Revised: 21 December 2023
Accepted: 3 January 2024
First Online: 8 February 2024
Disclosure and competing interests statement
: LO, EI, KT, GM, DC, and NK work or worked for AstraZeneca which develops treatments and vaccines against pathogens. The remaining authors declare no competing interests.
